, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
Synphate Co.,Ltd. The board of directors of Rmakhamhaeng Hospital Public Company Limited held on January 9th, 2020 passed the following resolution the acquisition of Vibharam Co.,Ltd.’s new ordinary shares
Page 1 of 2 Management Discussion and Analysis for the First Quarter of Year 2020 Business Overview Business overview of One to One Contacts Public Company Limited and its subsidiaries (“the Group
Food & Marketing Public Company Limited (the “Company”) would like clarify the revenue from sales and net profit in the consolidated financial statements for the three-month period ended March 31, 2020
LIMITED (“the Company”) would like to provide an explanation regarding our financial performance for the 3-months period ended 31 March 2020 as follows: Financial Performance Millions of THB % Millions of
government’s measures. The health and safety of our customers and associates remains our top priority. We rapidly transformed and adapted to the change in consumer behavior by utilizing the Company’s existing
the financial statements for the 2nd quarter ended June 30, 2020 Reference is made to our submission of J.S.P. Property Public Company Limited (“the Company”) reviewed consolidated financial statements
) Public Company Limited (the “Company”) would like to clarify its operation results for the Quarter3/FY2020 (ended June 30, 2020) of the Company and its subsidiaries, as follows: (unit: million baht) Q3
COMPANY LIMITED (“The Company”) would like to provide an explanation regarding our financial performance for the 9-months period ended 30 September 2020 as follows: Financial Performance Millions of THB
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the